Abstract

Los Angeles has been a major epicenter of the AIDS epidemic since the first cases of this disease were reported from UCLA in 1981. Over the last 29 years, both UCLA and USC have been major centers for research in HIV/AIDS and were two ofthe first institutions to become heavily involved in the treatment of pafients with AIDS related malignancies. These two institufions have chosen to form a combined AMC core site each with its unique strengths and leadership for the Group and to provide two locations where the diverse HIV populafion of Los Angeles may access AMC trials. The 2 institutions complement each others in their primary areas expertise and major disease populafions and trials enrollment. UCLA has primary interest and expertise in HPV, lymphoma and NADC while USC has chosen to focus more on KS, lymphoma and NADC.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA121947-05S1
Application #
8426573
Study Section
Special Emphasis Panel (ZCA1-SRLB-D)
Project Start
Project End
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
5
Fiscal Year
2012
Total Cost
$40,909
Indirect Cost

  Institution

Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095

  Publications

Ellsworth, G B; Lensing, S Y; Ogilvie, C B et al. (2018) A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men. Papillomavirus Res 6:11-14
Goldstone, Stephen E; Lensing, Shelly Y; Stier, Elizabeth A et al. (2018) A randomized clinical trial of infrared coagulation ablation versus active monitoring of intra-anal high-grade dysplasia in HIV-infected adults: An AIDS Malignancy Consortium trial. Clin Infect Dis :
Bender Ignacio, Rachel; Lin, Lilie L; Rajdev, Lakshmi et al. (2018) Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials. J Natl Compr Canc Netw 16:1018-1026
Danilov, Alexey V; Li, Hongli; Press, Oliver W et al. (2017) Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leuk Lymphoma 58:461-465
Oliver, Nora T; Chiao, Elizabeth Y (2017) Malignancies in women with HIV infection. Curr Opin HIV AIDS 12:69-76
Chinula, Lameck; Moses, Agnes; Gopal, Satish (2017) HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. Curr Opin HIV AIDS 12:89-95
Kohler, Racquel E; Miller, Anna R; Gutnik, Lily et al. (2017) Experiences and perceptions regarding clinical breast exam screening by trained laywomen in Malawi. Cancer Causes Control 28:137-143
Schneider, Johann W; Dittmer, Dirk P (2017) Diagnosis and Treatment of Kaposi Sarcoma. Am J Clin Dermatol 18:529-539
Palefsky, Joel M (2017) Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era. Curr Opin HIV AIDS 12:26-30
Faggons, Claire E; Mabedi, Charles E; Liomba, N George et al. (2017) Human papillomavirus in head and neck squamous cell carcinoma: A descriptive study of histologically confirmed cases at Kamuzu Central Hospital in Lilongwe, Malawi. Malawi Med J 29:142-145

Showing the most recent 10 out of 123 publications